Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
Chernyshov PV, Zouboulis CC, Tomas-Aragones L, Jemec GB, Svensson A, Manolache L, Tzellos T, Sampogna F, Pustisek N, van der Zee HH, Marron SE, Spillekom-van Koulil S, Bewley A, Linder D, Abeni D, Szepietowski JC, Augustin M, Finlay AY. Chernyshov PV, et al. Among authors: bewley a. J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1633-1643. doi: 10.1111/jdv.15519. Epub 2019 Apr 29. J Eur Acad Dermatol Venereol. 2019. PMID: 31037773
Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study.
Layton AM, Schaller M, Homey B, Hofmann MA, Bewley AP, Lehmann P, Nohlgård C, Sarwer DB, Kerrouche N, Ma YM. Layton AM, et al. Among authors: bewley ap. J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2405-10. doi: 10.1111/jdv.13305. Epub 2015 Sep 28. J Eur Acad Dermatol Venereol. 2015. PMID: 26416154 Free PMC article. Clinical Trial.
Quimp (quality of life impairment): an addition to the quality of life lexicon.
Chernyshov PV, Linder MD, Pustišek N, Manolache L, Szepietowski JC, Tomas-Aragones L, Marron SE, Poot F, Augustin M, Bewley A, van Cranenburgh OD, Jemec GB, Salek MS, Sampogna F, Svensson A. Chernyshov PV, et al. Among authors: bewley a. J Eur Acad Dermatol Venereol. 2018 May;32(5):e181-e182. doi: 10.1111/jdv.14693. Epub 2017 Dec 11. J Eur Acad Dermatol Venereol. 2018. PMID: 29135046 No abstract available.
Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study.
Reich K, Gooderham M, Bewley A, Green L, Soung J, Petric R, Marcsisin J, Cirulli J, Chen R, Piguet V. Reich K, et al. Among authors: bewley a. J Eur Acad Dermatol Venereol. 2018 Mar;32(3):397-402. doi: 10.1111/jdv.14738. Epub 2018 Jan 29. J Eur Acad Dermatol Venereol. 2018. PMID: 29220542 Free PMC article. Clinical Trial.
Patient perceptions of clear/almost clear skin in moderate-to-severe plaque psoriasis: results of the Clear About Psoriasis worldwide survey.
Armstrong A, Jarvis S, Boehncke WH, Rajagopalan M, Fernández-Peñas P, Romiti R, Bewley A, Vaid B, Huneault L, Fox T, Sodha M, Warren RB. Armstrong A, et al. Among authors: bewley a. J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2200-2207. doi: 10.1111/jdv.15065. Epub 2018 Jul 31. J Eur Acad Dermatol Venereol. 2018. PMID: 29730888
Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching-adjusted indirect comparison.
Bewley AP, Shear NH, Calzavara-Pinton PG, Hansen JB, Nyeland ME, Signorovitch J. Bewley AP, et al. J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1107-1115. doi: 10.1111/jdv.15369. Epub 2019 Mar 19. J Eur Acad Dermatol Venereol. 2019. PMID: 30472749 Free PMC article.
Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer.
Chernyshov PV, Lallas A, Tomas-Aragones L, Arenbergerova M, Samimi M, Manolache L, Svensson A, Marron SE, Sampogna F, Spillekom-vanKoulil S, Bewley A, Forsea AM, Jemec GB, Szepietowski JC, Augustin M, Finlay AY. Chernyshov PV, et al. Among authors: bewley a. J Eur Acad Dermatol Venereol. 2019 May;33(5):816-827. doi: 10.1111/jdv.15487. Epub 2019 Apr 8. J Eur Acad Dermatol Venereol. 2019. PMID: 30963614 Review.
290 results